PL1663347T3 - Urządzenie do rozdzielania elementów krwi - Google Patents

Urządzenie do rozdzielania elementów krwi

Info

Publication number
PL1663347T3
PL1663347T3 PL04761033T PL04761033T PL1663347T3 PL 1663347 T3 PL1663347 T3 PL 1663347T3 PL 04761033 T PL04761033 T PL 04761033T PL 04761033 T PL04761033 T PL 04761033T PL 1663347 T3 PL1663347 T3 PL 1663347T3
Authority
PL
Poland
Prior art keywords
apheresis device
apharesis
contacted
plasma
blood
Prior art date
Application number
PL04761033T
Other languages
English (en)
Inventor
Frank Mattner
Walter Schmidt
Original Assignee
Affiris Forschungs Und Entw Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34280361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1663347(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Affiris Forschungs Und Entw Gmbh filed Critical Affiris Forschungs Und Entw Gmbh
Publication of PL1663347T3 publication Critical patent/PL1663347T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
PL04761033T 2003-09-12 2004-09-13 Urządzenie do rozdzielania elementów krwi PL1663347T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0144403A AT413336B (de) 2003-09-12 2003-09-12 Apherese-vorrichtung
EP04761033A EP1663347B1 (de) 2003-09-12 2004-09-13 Apherese-vorrichtung
PCT/AT2004/000311 WO2005025651A1 (de) 2003-09-12 2004-09-13 Apherese-vorrichtung

Publications (1)

Publication Number Publication Date
PL1663347T3 true PL1663347T3 (pl) 2008-06-30

Family

ID=34280361

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04761033T PL1663347T3 (pl) 2003-09-12 2004-09-13 Urządzenie do rozdzielania elementów krwi

Country Status (15)

Country Link
US (2) US7935252B2 (pl)
EP (1) EP1663347B1 (pl)
JP (1) JP4509113B2 (pl)
CN (1) CN100556472C (pl)
AT (2) AT413336B (pl)
AU (1) AU2004271651B2 (pl)
CA (1) CA2538305C (pl)
CY (1) CY1107911T1 (pl)
DE (1) DE502004005851D1 (pl)
DK (1) DK1663347T3 (pl)
ES (1) ES2298789T3 (pl)
HR (1) HRP20080090T3 (pl)
PL (1) PL1663347T3 (pl)
PT (1) PT1663347E (pl)
WO (1) WO2005025651A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056318A2 (en) 2002-12-19 2004-07-08 New York University Method for treating amyloid disease
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT501621A1 (de) * 2005-03-15 2006-10-15 Mattner Frank Dr Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung
ES2332846B1 (es) * 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
WO2009082515A1 (en) * 2007-12-21 2009-07-02 Ge Healthcare Bio-Sciences Ab Method for sterilization of chemically activated solid support materials
US20100030196A1 (en) * 2008-07-29 2010-02-04 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
JP5432923B2 (ja) * 2008-12-22 2014-03-05 学校法人藤田学園 Ａβ除去材、Ａβ除去器及びＡβ除去システム
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
EP2497828A1 (en) * 2011-03-07 2012-09-12 Charité - Universitätsmedizin Berlin Use of aptamers in therapy and/or diagnosis of autoimmune diseases
EP2579042B1 (en) 2011-10-04 2014-07-09 Affiris AG Method for detecting Aß-specific antibodies in a biological sample
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
JP6876601B2 (ja) 2014-07-10 2021-05-26 アフィリス・アクチェンゲゼルシャフトＡｆｆｉｒｉｓ Ａｇ ハンチントン病の予防および／または処置における使用のための物質および方法
JP2017523165A (ja) 2014-07-10 2017-08-17 アフィリス・アクチェンゲゼルシャフトＡｆｆｉｒｉｓ Ａｇ ハンチントン病の予防および／または処置における使用のための薬剤および方法
US12227567B2 (en) 2017-07-25 2025-02-18 Truebinding, Inc. Treating cancer by blocking the interaction of TIM-3 and its ligand
GB201904810D0 (en) * 2019-04-05 2019-05-22 Cynapsedx Ltd The treatment of protein aggregation diseases
CA3185040A1 (en) 2020-05-26 2021-12-02 Truebinding, Inc. Methods of treating inflammatory diseases by blocking galectin-3

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
EP0236509B1 (en) 1985-09-19 1993-02-10 Toray Industries, Inc. B2-microglobulin-removing column
US5216127A (en) * 1987-11-20 1993-06-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent for serum amyloid protein
DE3853219T2 (de) * 1987-11-20 1995-06-29 Kanegafuchi Chemical Ind Methode zur Entfernung von Serum-Amyloid-Protein.
JPH01171638A (ja) * 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドａ蛋白用吸着体
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
JPH06104122A (ja) 1992-09-21 1994-04-15 Matsushita Electric Ind Co Ltd ロータリートランス
ATE294959T1 (de) * 1994-05-13 2005-05-15 Miltenyi Biotec Gmbh An protein gebundene sterile und pyrogenfreie säulen zum binden und entfernen von substanzen aus blut
DE19549420A1 (de) * 1995-04-27 1997-09-18 Braun Melsungen Ag Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose Faktor alpha (TNF alpha) und bakteriellen Lipopolysacchariden (LPS) aus Vollblut oder/und Blutplasma
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
SK288711B6 (sk) 2000-02-24 2019-11-05 Univ Washington Humanizovaná protilátka, jej fragment a ich použitie, polynukleová kyselina, expresný vektor, bunka a farmaceutický prostriedok
TWI238251B (en) * 2000-07-13 2005-08-21 Anawrhta Biotech Co Ltd In-vitro adsorbing device using immunity
US20050227941A1 (en) * 2001-12-17 2005-10-13 Karen Duff Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases
WO2004056318A2 (en) * 2002-12-19 2004-07-08 New York University Method for treating amyloid disease
AT413945B (de) * 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
AT413946B (de) * 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT500835B1 (de) * 2004-09-13 2007-12-15 Affiris Forschungs & Entwicklungs Gmbh Cholinestertransport-protein-mimotop als atherosklerose-medikament

Also Published As

Publication number Publication date
ES2298789T3 (es) 2008-05-16
AU2004271651B2 (en) 2009-08-06
WO2005025651A1 (de) 2005-03-24
JP2007504863A (ja) 2007-03-08
CN1867365A (zh) 2006-11-22
EP1663347B1 (de) 2008-01-02
US7935252B2 (en) 2011-05-03
CA2538305A1 (en) 2005-03-24
ATE382383T1 (de) 2008-01-15
HK1096320A1 (zh) 2007-06-01
ATA14442003A (de) 2005-07-15
JP4509113B2 (ja) 2010-07-21
AU2004271651A1 (en) 2005-03-24
US20110166327A1 (en) 2011-07-07
CN100556472C (zh) 2009-11-04
CA2538305C (en) 2011-05-24
HRP20080090T3 (hr) 2008-03-31
US20070026029A1 (en) 2007-02-01
AT413336B (de) 2006-02-15
CY1107911T1 (el) 2013-09-04
PT1663347E (pt) 2008-03-28
DE502004005851D1 (de) 2008-02-14
EP1663347A1 (de) 2006-06-07
DK1663347T3 (da) 2008-05-19

Similar Documents

Publication Publication Date Title
PL1663347T3 (pl) Urządzenie do rozdzielania elementów krwi
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
WO2008050148A3 (en) Therapy for liver disease
JO3076B1 (ar) نظم العلاج المناعي المعتمد على حالة apoe
IL249263B (en) Method for ex-vivo organ care
DE60308293D1 (de) Blutbehandlungskathetereinrichtung
EP1685802A4 (en) MEDICAL TREATMENT INSTRUMENT
ATE474617T1 (de) Medizinproduktsysteme
TW200637522A (en) Skin treatment articles and methods
EP1883441A4 (en) CATHETER PORT ASSEMBLY FOR EXTRACORPOREAL TREATMENT
MX339116B (es) Tratamiento de esclerosis tuberosa.
PL2054104T3 (pl) Urządzenie do pozaustrojowej obróbki krwi i sposób przygotowywania obróbki krwi za pomocą urządzenia do pozaustrojowej obróbki krwi
WO2007137224A3 (en) Method of treatment
EP1683492A4 (en) MEDICAL TREATMENT INSTRUMENT
PL2091589T3 (pl) Urządzenie do pozaustrojowej obróbki krwi
SG146451A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
IL178827A0 (en) Use of reboxetine for the treatment of pain
ATE515280T1 (de) Vorrichtung zur intermittierenden okklusion des koronarsinus
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
UA88655C2 (ru) S-миртазапин для лечения прилива крови
PL1677858T3 (pl) Urządzenie do obliczania przepływu krwi i aparat do oczyszczania krwi wykorzystujący to urządzenie
GB2412319B (en) Fluid treatment system
GB0512593D0 (en) Treatment device for the human body
ZA200609007B (en) Medical plaster for application on the skin
CA115177S (en) Blood or plasma treatment apparatus